Form D · Biotechnology
Onconaut Therapeutics, Inc.
Aurora, CO · CIK 0002042684
Offering snapshot reported Nov 4, 2024 · SEC filing
- Reported sold
- $125K Offering amount: $125K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 21, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2024 | Initial | $125,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-528575
Promissory note convertible into equity securities of the Issuer and the equity securities to be issued upon such conversion
Source: Form D, filed Nov 4, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel V. La Barbera | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
27604 E. Euclid Drive
Aurora, CO, 80016
Aurora, CO, 80016